+476,136.5%
NVDA vs THC
+419.4%
+475,717.1%
-89.7%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -4.3% | +2.0% | -6.3% | -4.6% |
| 7D | -11.6% | +7.5% | -19.1% | -12.8% |
| 30D | -22.1% | +9.6% | -31.6% | -23.5% |
| 3M | -20.1% | +10.3% | -30.4% | -21.8% |
| 6M | -16.8% | +51.8% | -68.6% | -23.8% |
| YTD | -4.0% | +45.4% | -49.4% | -11.8% |
| 1Y | -4.8% | +40.8% | -45.6% | -12.3% |
| 3Y | +281.7% | +448.8% | -167.1% | +167.7% |
| 5Y | +485.4% | +263.4% | +222.0% | +334.3% |
| 10Y | +10,310.1% | +1,800.1% | +8,510.0% | +4,977.0% |
| All | +476,136.5% | +419.4% | +475,717.1% | +214,787.5% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling